Fly News Breaks for December 19, 2019
Dec 19, 2019 | 16:30 EDT
Mizuho analyst Omotayo Okusanya initiated coverage of Welltower with a Buy rating and $92 price target. The analyst says the REIT's premium multiple relative to the "big 3" healthcare peers is sustainable in 2020 as he sees the company delivering the best earnings growth. Okusanya contends that Welltower has developed a "competitive advantage by actively using technology to identify opportunities/threats within the portfolio and repositioning accordingly as well as in its active relationship management with tenants and "smart deal making".
News For WELL From the Last 2 Days
There are no results for your query WELL